ID   IKZF5_HUMAN             Reviewed;         419 AA.
AC   Q9H5V7; B3KVH7; D3DRE7; Q9H2T0;
DT   11-SEP-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   28-JUN-2023, entry version 171.
DE   RecName: Full=Zinc finger protein Pegasus;
DE   AltName: Full=Ikaros family zinc finger protein 5;
GN   Name=IKZF5; Synonyms=ZNFN1A5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, AND INTERACTION
RP   WITH IKZF1; IKZF2; IKZF3 AND IKZF4.
RX   PubMed=10978333; DOI=10.1074/jbc.m005457200;
RA   Perdomo J., Holmes M., Chong B., Crossley M.;
RT   "Eos and pegasus, two members of the Ikaros family of proteins with
RT   distinct DNA binding activities.";
RL   J. Biol. Chem. 275:38347-38354(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Synovial cell;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Endometrial adenocarcinoma, and Testis carcinoma;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (DEC-2006) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [7]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-5, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [8]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-5, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [9]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-5, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.o114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to replication
RT   stress reveals novel small ubiquitin-like modified target proteins and
RT   acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [10]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-5 AND LYS-185, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [11]
RP   FUNCTION, SUBCELLULAR LOCATION, INVOLVEMENT IN THC7, AND MUTAGENESIS OF
RP   TYR-89; ARG-96; ILE-98; GLY-134; CYS-140; HIS-155 AND SER-200.
RX   PubMed=31217188; DOI=10.1182/blood.2019000782;
RG   NIHR BioResource;
RA   Lentaigne C., Greene D., Sivapalaratnam S., Favier R., Seyres D., Thys C.,
RA   Grassi L., Mangles S., Sibson K., Stubbs M., Burden F., Bordet J.C.,
RA   Armari-Alla C., Erber W., Farrow S., Gleadall N., Gomez K., Megy K.,
RA   Papadia S., Penkett C.J., Sims M.C., Stefanucci L., Stephens J.C.,
RA   Read R.J., Stirrups K.E., Ouwehand W.H., Laffan M.A., Frontini M.,
RA   Freson K., Turro E.;
RT   "Germline mutations in the transcription factor IKZF5 cause
RT   thrombocytopenia.";
RL   Blood 134:2070-2081(2019).
RN   [12]
RP   VARIANTS THC7 VARIANT HIS-16 AND PRO-119.
RX   PubMed=32419556; DOI=10.1080/09537104.2020.1764921;
RA   Leinoe E., Kjaersgaard M., Zetterberg E., Ostrowski S., Greinacher A.,
RA   Rossing M.;
RT   "Highly impaired platelet ultrastructure in two families with novel IKZF5
RT   variants.";
RL   Platelets 32:492-497(2021).
CC   -!- FUNCTION: Transcriptional repressor that binds the core 5'GNNTGTNG-3'
CC       DNA consensus sequence (PubMed:10978333, PubMed:31217188). Involved in
CC       megakaryocyte differentiation. {ECO:0000269|PubMed:10978333,
CC       ECO:0000269|PubMed:31217188}.
CC   -!- SUBUNIT: Self-associates. Interacts with other family members; IKZF1,
CC       IKZF2, IKZF3 and IKZF4. {ECO:0000269|PubMed:10978333}.
CC   -!- INTERACTION:
CC       Q9H5V7; Q9UKT9: IKZF3; NbExp=2; IntAct=EBI-2685636, EBI-747204;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:31217188}.
CC   -!- TISSUE SPECIFICITY: Expressed in brain, heart, skeletal muscle, kidney,
CC       and liver. Expressed in the hematopoietic cell lines MOLT-4, NALM-6 and
CC       K-562. Highly expressed in THP-1 and M-07e cell lines, which have
CC       characteristics of myeloid and early megakaryocytic cells respectively.
CC       {ECO:0000269|PubMed:10978333}.
CC   -!- DOMAIN: The N-terminal zinc fingers are involved in sequence-specific
CC       DNA binding and heterotypic associations with other family members.
CC   -!- DOMAIN: C-terminal zinc fingers mediate homodimerization.
CC   -!- DISEASE: Thrombocytopenia 7 (THC7) [MIM:619130]: A form of
CC       thrombocytopenia, a hematologic disorder defined by a decrease in the
CC       number of platelets in circulating blood, resulting in the potential
CC       for increased bleeding and decreased ability for clotting. THC7 is an
CC       autosomal dominant form with highly variable severity, ranging from
CC       absence of bleeding symptoms to epistaxis or more severe bleeding
CC       episodes. {ECO:0000269|PubMed:31217188, ECO:0000269|PubMed:32419556}.
CC       Note=The disease may be caused by variants affecting the gene
CC       represented in this entry.
CC   -!- MISCELLANEOUS: 'Pegasus' was the winged horse in Greek mythology.
CC   -!- SIMILARITY: Belongs to the Ikaros C2H2-type zinc-finger protein family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF230808; AAG39220.1; -; mRNA.
DR   EMBL; AK026626; BAB15512.1; -; mRNA.
DR   EMBL; AK122899; BAG53789.1; -; mRNA.
DR   EMBL; CR749800; CAH18660.1; -; mRNA.
DR   EMBL; BX647958; CAH56199.1; -; mRNA.
DR   EMBL; CH471066; EAW49292.1; -; Genomic_DNA.
DR   EMBL; CH471066; EAW49293.1; -; Genomic_DNA.
DR   EMBL; CH471066; EAW49294.1; -; Genomic_DNA.
DR   CCDS; CCDS41574.1; -.
DR   RefSeq; NP_001258769.1; NM_001271840.1.
DR   RefSeq; XP_006718010.1; XM_006717947.3.
DR   RefSeq; XP_016872039.1; XM_017016550.1.
DR   RefSeq; XP_016872040.1; XM_017016551.1.
DR   RefSeq; XP_016872041.1; XM_017016552.1.
DR   AlphaFoldDB; Q9H5V7; -.
DR   SMR; Q9H5V7; -.
DR   BioGRID; 122147; 65.
DR   IntAct; Q9H5V7; 56.
DR   STRING; 9606.ENSP00000357881; -.
DR   iPTMnet; Q9H5V7; -.
DR   PhosphoSitePlus; Q9H5V7; -.
DR   BioMuta; IKZF5; -.
DR   DMDM; 74761459; -.
DR   EPD; Q9H5V7; -.
DR   jPOST; Q9H5V7; -.
DR   MassIVE; Q9H5V7; -.
DR   MaxQB; Q9H5V7; -.
DR   PaxDb; Q9H5V7; -.
DR   PeptideAtlas; Q9H5V7; -.
DR   ProteomicsDB; 80932; -.
DR   Antibodypedia; 9078; 71 antibodies from 19 providers.
DR   DNASU; 64376; -.
DR   Ensembl; ENST00000368886.10; ENSP00000357881.5; ENSG00000095574.12.
DR   Ensembl; ENST00000617859.4; ENSP00000478056.1; ENSG00000095574.12.
DR   GeneID; 64376; -.
DR   KEGG; hsa:64376; -.
DR   MANE-Select; ENST00000368886.10; ENSP00000357881.5; NM_001372123.1; NP_001359052.1.
DR   UCSC; uc001lha.4; human.
DR   AGR; HGNC:14283; -.
DR   CTD; 64376; -.
DR   DisGeNET; 64376; -.
DR   GeneCards; IKZF5; -.
DR   HGNC; HGNC:14283; IKZF5.
DR   HPA; ENSG00000095574; Low tissue specificity.
DR   MalaCards; IKZF5; -.
DR   MIM; 606238; gene.
DR   MIM; 619130; phenotype.
DR   neXtProt; NX_Q9H5V7; -.
DR   OpenTargets; ENSG00000095574; -.
DR   Orphanet; 168629; Autosomal thrombocytopenia with normal platelets.
DR   PharmGKB; PA162391969; -.
DR   VEuPathDB; HostDB:ENSG00000095574; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   GeneTree; ENSGT00940000155035; -.
DR   HOGENOM; CLU_734778_0_0_1; -.
DR   InParanoid; Q9H5V7; -.
DR   OMA; FMIQQPT; -.
DR   OrthoDB; 2948149at2759; -.
DR   PhylomeDB; Q9H5V7; -.
DR   TreeFam; TF331860; -.
DR   PathwayCommons; Q9H5V7; -.
DR   SignaLink; Q9H5V7; -.
DR   SIGNOR; Q9H5V7; -.
DR   BioGRID-ORCS; 64376; 11 hits in 1182 CRISPR screens.
DR   ChiTaRS; IKZF5; human.
DR   GenomeRNAi; 64376; -.
DR   Pharos; Q9H5V7; Tbio.
DR   PRO; PR:Q9H5V7; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; Q9H5V7; protein.
DR   Bgee; ENSG00000095574; Expressed in endothelial cell and 181 other tissues.
DR   Genevisible; Q9H5V7; HS.
DR   GO; GO:0005634; C:nucleus; IMP:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IMP:CAFA.
DR   GO; GO:0003682; F:chromatin binding; IMP:UniProtKB.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IBA:GO_Central.
DR   GO; GO:0001227; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; IDA:NTNU_SB.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:CAFA.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0008270; F:zinc ion binding; IMP:CAFA.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:NTNU_SB.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   Gene3D; 3.30.160.60; Classic Zinc Finger; 4.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   PANTHER; PTHR24379:SF67; BLOODY FINGERS-RELATED; 1.
DR   PANTHER; PTHR24379; KRAB AND ZINC FINGER DOMAIN-CONTAINING; 1.
DR   SMART; SM00355; ZnF_C2H2; 5.
DR   SUPFAM; SSF57667; beta-beta-alpha zinc fingers; 3.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 3.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 4.
PE   1: Evidence at protein level;
KW   Disease variant; DNA-binding; Isopeptide bond; Metal-binding; Nucleus;
KW   Reference proteome; Repeat; Repressor; Transcription;
KW   Transcription regulation; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..419
FT                   /note="Zinc finger protein Pegasus"
FT                   /id="PRO_0000299471"
FT   ZN_FING         82..104
FT                   /note="C2H2-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         110..132
FT                   /note="C2H2-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         138..161
FT                   /note="C2H2-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         364..386
FT                   /note="C2H2-type 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         392..416
FT                   /note="C2H2-type 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   REGION          223..247
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          262..356
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        287..352
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CROSSLNK        5
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:25218447,
FT                   ECO:0007744|PubMed:25755297, ECO:0007744|PubMed:25772364,
FT                   ECO:0007744|PubMed:28112733"
FT   CROSSLNK        185
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   VARIANT         16
FT                   /note="Q -> H (in THC7; unknown pathological significance)"
FT                   /evidence="ECO:0000269|PubMed:32419556"
FT                   /id="VAR_085558"
FT   VARIANT         119
FT                   /note="S -> P (in THC7; unknown pathological significance)"
FT                   /evidence="ECO:0000269|PubMed:32419556"
FT                   /id="VAR_085559"
FT   MUTAGEN         89
FT                   /note="Y->C: Decreased protein abundance. Decreased
FT                   chromatin binding. Decreased localization to the nucleus.
FT                   Tends to remain in the cytosol."
FT                   /evidence="ECO:0000269|PubMed:31217188"
FT   MUTAGEN         96
FT                   /note="R->W: Decreased protein abundance. Decreased
FT                   chromatin binding. Decreased localization to the nucleus.
FT                   Tends to remain in the cytosol."
FT                   /evidence="ECO:0000269|PubMed:31217188"
FT   MUTAGEN         98
FT                   /note="I->V: No effect on protein abundance. No effect on
FT                   chromatin binding. No effect on localization to the
FT                   nucleus."
FT                   /evidence="ECO:0000269|PubMed:31217188"
FT   MUTAGEN         134
FT                   /note="G->E: Decreased protein abundance. Decreased
FT                   chromatin binding. Decreased localization to the nucleus.
FT                   Tends to remain in the cytosol."
FT                   /evidence="ECO:0000269|PubMed:31217188"
FT   MUTAGEN         140
FT                   /note="C->R: Decreased protein abundance. Decreased
FT                   chromatin binding. Decreased localization to the nucleus.
FT                   Tends to remain in the cytosol."
FT                   /evidence="ECO:0000269|PubMed:31217188"
FT   MUTAGEN         155
FT                   /note="H->Y: Decreased protein abundance. Decreased
FT                   chromatin binding. Decreased localization to the nucleus.
FT                   Tends to remain in the cytosol."
FT                   /evidence="ECO:0000269|PubMed:31217188"
FT   MUTAGEN         200
FT                   /note="S->G: No effect on protein abundance. No effect on
FT                   chromatin binding. No effect on localization to the
FT                   nucleus."
FT                   /evidence="ECO:0000269|PubMed:31217188"
FT   CONFLICT        209
FT                   /note="P -> L (in Ref. 1; AAG39220)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   419 AA;  46510 MW;  71845E9DE10BB2E8 CRC64;
     MGEKKPEPLD FVKDFQEYLT QQTHHVNMIS GSVSGDKEAE ALQGAGTDGD QNGLDHPSVE
     VSLDENSGML VDGFERTFDG KLKCRYCNYA SKGTARLIEH IRIHTGEKPH RCHLCPFASA
     YERHLEAHMR SHTGEKPYKC ELCSFRCSDR SNLSHHRRRK HKMVPIKGTR SSLSSKKMWG
     VLQKKTSNLG YSRRALINLS PPSMVVQKPD YLNDFTHEIP NIQTDSYESM AKTTPTGGLP
     RDPQELMVDN PLNQLSTLAG QLSSLPPENQ NPASPDVVPC PDEKPFMIQQ PSTQAVVSAV
     SASIPQSSSP TSPEPRPSHS QRNYSPVAGP SSEPSAHTST PSIGNSQPST PAPALPVQDP
     QLLHHCQHCD MYFADNILYT IHMGCHGYEN PFQCNICGCK CKNKYDFACH FARGQHNQH
//
